Travere Therapeutics, Inc.
TVTX NASDAQHealthcare ★★★★★Latest Earnings Below forecast↓
Date
Aug 4, 2026
ET
EPS Est.
-0.13
EPS Actual
-0.37
Revenue Est.
$157.3M
Revenue Actual
$169.6M
Next Earnings Report
Date
Oct 29, 2026 · Thu
Time
Your time zone matches ET
After-market(ET)
Fiscal Period
FY2026 Q3
EPS Est.
0.03
Revenue Est.
$195.2M
Company Overview
Travere Therapeutics, Inc. (ticker TVTX) is listed on NASDAQ with a market cap of about $6.11B. Its next earnings report (FY2026 Q3) is expected on Oct 29, 2026 (ET), After-market, with consensus EPS of 0.03. In the last 15 reported quarters, EPS beat consensus estimates 6 times.
Actual EPS TrendRecently15Term · Feb 23, 2023 → Aug 4, 2026
Feb 23, 2023Range: -1.76 ~ 0.28Aug 4, 2026
Earnings History
| Date | Fiscal Period | EPS Est. | EPS Actual | Revenue Est. | Revenue Actual |
|---|---|---|---|---|---|
| Aug 4, 2026 | -- | -0.13 | Below forecast↓-0.37 | $157.3M | $169.6M |
| May 4, 2026 | -- | -0.30 | Below forecast↓-0.39 | $136.2M | $127.2M |
| Feb 19, 2026 | -- | 0.03 | 0.03 | $144.6M | $129.7M |
| Oct 30, 2025 | -- | -0.31 | Above forecast↑0.28 | $147M | $164.9M |
| Aug 6, 2025 | -- | -0.28 | Above forecast↑-0.14 | $99.5M | $114.4M |
| May 1, 2025 | -- | -0.55 | -0.47 | $88.8M | $81.7M |
| Feb 20, 2025 | -- | -0.58 | Below forecast↓-0.73 | $72.4M | $74.8M |
| Oct 31, 2024 | -- | -0.70 | -0.70 | $71.4M | $62.9M |
| Aug 1, 2024 | -- | -0.87 | -0.90 | $57.8M | $54.1M |
| May 6, 2024 | -- | -0.98 | Below forecast↓-1.76 | $42.9M | $41.4M |
| Feb 15, 2024 | -- | -1.27 | -1.16 | $41.5M | $45.1M |
| Nov 7, 2023 | -- | -1.09 | -1.17 | $117.3M | $37.1M |
| Aug 3, 2023 | -- | -1.16 | -1.13 | $53.7M | $59.7M |
| May 4, 2023 | -- | -1.18 | -1.27 | $50.6M | $57M |
| Feb 23, 2023 | -- | -1.04 | -1.03 | $53M | $55.9M |
Original Filings (SEC)
Quarterly10-Q · 2026-08-04 ↗
Earnings Release8-K · 2026-08-04 ↗
Quarterly10-Q · 2026-05-04 ↗
Earnings Release8-K · 2026-05-04 ↗
Annual10-K · 2026-02-19 ↗
Earnings Release8-K · 2026-02-19 ↗
Quarterly10-Q · 2025-10-30 ↗
Links point to the company's original filings on the U.S. Securities and Exchange Commission (SEC) website.
Report dates are US trading days (Eastern Time); EPS and revenue estimates are market consensus, in USD. This page is for reference only and does not constitute investment advice.
